Response to Letter to Editor by A. Derbalah et al.: the role of automation in enhancing reproducibility and interoperability of PBPK models
Elena Domínguez-Romero, Stanislav Mazurenko, Martin Scheringer, Vítor A P Martins dos Santos, Chris T Evelo, Mihail Anton, John M Hancock, Anže Županič, Maria Suarez-Diez

Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCerebrospinal fluid and hydrocephalus · Traumatic Brain Injury and Neurovascular Disturbances · Respiratory Support and Mechanisms
Dear colleagues,
We thank you for your comments on our manuscript [1] and for raising the important question of automation [2].
The publications by Sepp et al. (2019) [3] and Liu et al. (2024) [4] focus on one type of PBPK models, denominated ‘for biologics’. In these models, each compartment (tissue/organ) is divided into vascular, endothelial endosomal and interstitial (sub-)compartments, and lymphatic flows are also represented [3, 4]. In these examples, the pharmacokinetics of proteins are represented. Notably, the protein distribution within tissues includes processes of passive transport across two types of pores via diffusion or fluid convection, processes of pinocytosis, binding, recycling and degradation [4]. This type of PBPK models is complex and their authors successfully used specific tools for automated code generation. In particular, Liu et al. (2024) used ‘mathematical sets’ available in the Ubiquity package, which facilitates assembling model components in R-language [4]. Sepp et al. (2019) used the MATLAB script PBPKassembler.m for automated code generation, where files in Simbiology (MATLAB) and Excel formats were combined [3].
Briefly, automation can help build models, which is highly valuable notably for complex models. Having a robust, thoroughly validated platform for automated code generation will indeed contribute to accessibility and reproducibility. Also, automation of model building seems to be a natural way to address the case of large models, in which manual scripting will be prone to introducing errors.
Smaller models or those with fewer equations do not necessarily require automation. From our experience, writing the script manually provides a deep understanding of the underlying model mechanics. Manually written scripts also allow to give a clear view of how equations and parameters are applied, which we consider especially valuable for teaching and knowledge transfer.
To conclude, as observed in other niches of systems biology, automation brings significant benefits to the modelling field, e.g. there is a plethora of tools that reconstruct and benchmark genome-scale metabolic models. As the correspondence authors argue, there is more scope for automation in the current practices of PBPK modelling. To facilitate this, we have opted to begin the journey of standardization via open collaboration through ELIXIR. We are looking forward to continuing to engage the research community towards automatic construction, validation and deposition of PBPK models.
Thank you. Best regards,
Elena Domínguez-Romero, Stanislav Mazurenko, Martin Scheringer, Vítor Martins dos Santos, Chris Evelo, Mihail Anton, John M. Hancock, Anže Županič, and Maria Suarez-Diez.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Domínguez-Romero E, Mazurenko S, Scheringer M. et al. Making PBPK models more reproducible in practice. Brief Bioinform 2024;25:bbae 569. 10.1093/bib/bbae 56939494970 PMC 11533111 · doi ↗ · pubmed ↗
- 2Derbalah A, Jamei M, Gardner I. et al. The role of automation in enhancing reproducibility and interoperability of PBPK models, Letter to Editor. Brief Bioinform 2025.
- 3Sepp A, Meno-Tetang G, Weber A. et al. Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats. J Pharmacokinet Pharmacodyn 2019;46:339–59. 10.1007/s 10928-019-09640-931079322 · doi ↗ · pubmed ↗
- 4Liu S, Li Y, Li Z. et al. Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins. J Pharmacokinet Pharmacodyn 2024;51:449–76. 10.1007/s 10928-024-09922-x 38691205 · doi ↗ · pubmed ↗
